A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India

BackgroundThe medical management of DT comprises tyrosine kinase inhibitors (TKIs), hormonal agents, anti-inflammatory drugs with the recently approved gamma secretase inhibitor nirogacestat being the current standard of care. Real-world data on evolving treatment landscapes of DT remains scarce.Met...

Полное описание

Библиографические подробности

Главные авторы:	Ghazal Tansir, Aparna Sharma, Bivas Biswas, Suryadev Narayan Sah, Somnath Roy, S. V. S. Deo, Sandeep Agarwala, Shah Alam Khan, Sameer Bakhshi, Deepam Pushpam
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2024-10-01
Серии:	Frontiers in Oncology
Предметы:	Desmoid tumor tyrosine kinase inhibitors oral metronomic therapy quality of life rare diseases
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1382856/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!